Table 7. Histomorphometry in subjects who had follow-up biopsies

PatientBV/TV %BV/TV2 %TbTh μmTbTh2 μmOsTh μmOsTh2 μmOB/100 mmboneOB/1002 mmboneOC/100 mmboneOC/1002 mmboneEDE μmEDE2 μmMLT2 daysAcFy2
Pamidronate
    1P10.4519.02142.29213.805.338.70000000008.12NA4.870.01
    2P45.2248.02154.36147.488.7011.5900000026.4733.5428.91NA0.01
    3P24.7323.69100.84100.5710.606.32376.622.9456.492.9412.6410.6718480.20
    4P26.0025.54102.5494.727.5716.43255.08113.04149.447.9610.906.4192.20.20
    5P24.7030.16116.60127.958.655.65196.2011.76167.4247.0313.4913.62NA0.01
    6P31.8514.09105.8268.796.055.80135.8330.4555.2523.689.934.933060.06
Controls
    1C33.8126.49118.57102.7610.049.9900144.0463.1827.9515.807.6341.080.61
    2C32.1723.63124.6097.267.486.944.7735.484.775.07NANANA0.01
    3C24.1026.19227.72160.296.559.78004.0910.180013.3515.02258.40.70
    4C26.1922.15153.91121.497.127.42112.15003.620013.2718.7599.70.07
    5C19.3023.90124.17132.199.85.98194.043.4167.320032.8717.8367.940.64
    6C29.6649.37112.80126.608.708.29147.54113.7258.5528.4314.7013.6187.10.23
    7C28.7920.94129.2391.5510.028.430018.8419.348.0744.1223.52NANA
    8C31.4915.01150.4692.268.175.33000029.420024.6314.23NA0.01